US Edition
Lindt says GLP-1 users are eating more chocolate, not less
4 Articles
4 Articles
Chocolate sales are increasing faster among U.S. users of GLP-1 weight loss drugs than in the rest of the population, according to Swiss chocolate manufacturer Lindt & Spruengli, who cites data that contradicts forecasts that this type of medicine would reduce the demand for confectionery products this Tuesday.
The sales of chocolate are growing faster among US users of drugs for the weakness of the GLP-1 class than in the rest of the population, said in March the Swiss chocolate producer Lindt & Spruengli, reading data that contradicts the expectations that these medicines would reduce the demand for coffee products, reports Reuters. The company claims that a ...
Lindt says GLP-1 users are eating more chocolate, not less
By Danny Callaghan and Bernadette Hogg March 10 (Reuters) – Chocolate sales are rising faster among U.S. users of GLP-1 weight-loss drugs than in the rest of the population, Swiss chocolatier Lindt & Spruengli said on Tuesday, citing data that went against expectations the drugs would reduce confectionery demand. The company said an internal study, based on February data from market researcher Circana, found 15% of U.S. households use GLP-…
Analysts had expected candy sales to decline as the use of GLP-1 weight-loss drugs like Ozempic and Mounjaro expanded, but chocolate retailer Lindt says the trend is the opposite.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
